Altre lingue Quoin Pharmaceuticals, Ltd.

Azioni

QNRX

US74907L3006

Tempo differito Nasdaq Altri mercati azionari 19:30:00 03/07/2024			Variaz. 5gg	Var. 1 gen.
0,5797 ^USD	+0,38%		-1,75%	-88,18%

27/06	Quoin Pharmaceuticals, Ltd. annuncia l'espansione internazionale degli studi clinici in corso per la sindrome di Netherton	CI
09/05	Quoin Pharmaceuticals, Ltd. Riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Quoin Pharmaceuticals Announces International Expansion of Ongoing Clinical Trials for Netherton Syndrome	27/06
Quoin Pharmaceuticals, Ltd. Announces International Expansion of Ongoing Clinical Trials for Netherton Syndrome	27/06
Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National Conference	25/06
Quoin Pharmaceuticals Announces Signing of Research Agreement with University College Cork (UCC), Ireland	12/06
Certain Options of Quoin Pharmaceuticals, Ltd. are subject to a Lock-Up Agreement Ending on 6-JUN-2024.	06/06
Certain Warrants of Quoin Pharmaceuticals, Ltd. are subject to a Lock-Up Agreement Ending on 6-JUN-2024.	06/06
Certain American Depositary Shares of Quoin Pharmaceuticals, Ltd. are subject to a Lock-Up Agreement Ending on 6-JUN-2024.	06/06
Quoin Pharmaceuticals, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial Results	09/05
Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024	02/05
Quoin Pharmaceuticals Seeks M&A Opportunities	14/03
Quoin Pharmaceuticals, Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	13/03
Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results	13/03
Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET	07/03
ADRs Close Higher; Dada Nexus Ltd. Climbs 30%	06/03
ADRs Slump, Quoin Pharmaceuticals Ltd. Declines 48.3%	05/03
Top Midday Decliners	05/03
Quoin Pharmaceuticals Prices $6.5 Million Public Offering; Shares Fall	05/03
Top Premarket Decliners	05/03
Quoin Pharmaceuticals Announces Pricing of $6.5 Million Public Offering	05/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Quoin Pharmaceuticals, Ltd.

Azioni

QNRX

US74907L3006

Altre lingue

Filtri